Loading…

Patheon signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina from Roche Holdings for an immaterial sum plus inventory and spare parts. The deal includes a multi-year supply arrangement with Roche.
“Patheon N.V. announced that it has signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina, from Roche Holdings, Inc.”businesswire.com
Summarized from public sources; check the original articles before acting on it.